232 related articles for article (PubMed ID: 29034884)
1. Generation of six multiple sclerosis patient-derived induced pluripotent stem cell lines.
Miquel-Serra L; Duarri A; Muñoz Y; Kuebler B; Aran B; Costa C; Martí M; Comabella M; Malhotra S; Montalban X; Veiga A; Raya A
Stem Cell Res; 2017 Oct; 24():155-159. PubMed ID: 29034884
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patient.
Lotila J; Hyvärinen T; Skottman H; Airas L; Narkilahti S; Hagman S
Stem Cell Res; 2022 Aug; 63():102865. PubMed ID: 35843021
[TBL] [Abstract][Full Text] [Related]
3. Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel.
Gao X; Yourick JJ; Sprando RL
Stem Cell Res; 2018 Aug; 31():193-196. PubMed ID: 30099336
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
5. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterisation of four multiple sclerosis iPSC lines from a single family.
Fortune AJ; Taylor BV; Charlesworth JC; Burdon KP; Blackburn NB; Fletcher JL; Mehta A; Young KM
Stem Cell Res; 2022 Jul; 62():102828. PubMed ID: 35679759
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Human Induced Pluripotent Stem Cells from Multiple Sclerosis Patients.
Begentas OC; Koc D; Kiris E
Methods Mol Biol; 2022; 2549():43-67. PubMed ID: 34988943
[TBL] [Abstract][Full Text] [Related]
8. Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis.
Mutukula N; Man Z; Takahashi Y; Iniesta Martinez F; Morales M; Carreon-Guarnizo E; Hernandez Clares R; Garcia-Bernal D; Martinez Martinez L; Lajara J; Nuñez Delicado E; Meca Lallana JE; Izpisua Belmonte JC
Stem Cell Res; 2021 May; 53():102319. PubMed ID: 33894548
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
10. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Song B; Sun G; Herszfeld D; Sylvain A; Campanale NV; Hirst CE; Caine S; Parkington HC; Tonta MA; Coleman HA; Short M; Ricardo SD; Reubinoff B; Bernard CC
Stem Cell Res; 2012 Mar; 8(2):259-73. PubMed ID: 22265745
[TBL] [Abstract][Full Text] [Related]
11. Generation of sibling-matched induced pluripotent stem cell lines from spinal and bulbar muscular atrophy patients.
Narayanan G; Sheila M; Chai J; Stanton LW
Stem Cell Res; 2017 Apr; 20():30-33. PubMed ID: 28395737
[TBL] [Abstract][Full Text] [Related]
12. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
[TBL] [Abstract][Full Text] [Related]
13. Generation of three spinocerebellar ataxia type-12 patients derived induced pluripotent stem cell lines (IGIBi002-A, IGIBi003-A and IGIBi004-A).
Kumar D; Hussain A; Srivastava AK; Mukerji M; Mukherjee O; Faruq M
Stem Cell Res; 2018 Aug; 31():216-221. PubMed ID: 30130680
[TBL] [Abstract][Full Text] [Related]
14. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.
Hong SG; Yada RC; Choi K; Carpentier A; Liang TJ; Merling RK; Sweeney CL; Malech HL; Jung M; Corat MAF; AlJanahi AA; Lin Y; Liu H; Tunc I; Wang X; Palisoc M; Pittaluga S; Boehm M; Winkler T; Zou J; Dunbar CE
Mol Ther; 2017 Jan; 25(1):44-53. PubMed ID: 28129126
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
17. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).
Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
